Bayer/Bion settle patent case in Korea
Bayer CropScience and Taiwan-based Chinese biopesticide company Bion Tech have settled a patent infringement case in South Korea. Bayer has granted Bion Tech a royalty-bearing licence to sell lipopeptide-containing products based on Bion Tech’s proprietary Bacillus subtilis Y1336 strain. Bion Tech's strain Y1336 produces agrastatin, which is covered by claims related to lipopeptides in Bayer’s patent portfolio related to the biopesticide, Serenade (B subtilis strain QST 713). The licence extends to various countries, with a focus on Asia.